Science
Mechanism of Action
This synthetic recombinant peptide precisely mimics human Insulin-like Growth Factor-2 (IGF-2), engaging specific skin cell membrane receptors to exert an insulin-like effect. It actively stimulates the proliferation and migration of dermal fibroblasts, significantly boosting the natural production of collagen. This comprehensive action facilitates the dynamic restoration of all skin layers, reinforcing intercellular connections and consequently thickening the skin's overall structure.
Research
Clinical Evidence
Medium confidenceN/A
Key findings
- 01 Reported to reduce wrinkles, increase skin density, and tighten the skin when incorporated into skincare formulations.
Transparency
Dusting Analysis
There is no available data to suggest that RH-POLYPEPTIDE-31 is commonly dusted or used at ineffective concentrations in formulations.
The Formula
Formulation
Stability
As a peptide, sh-Polypeptide-31's stability in aqueous solutions is critically dependent on environmental factors. It is susceptible to various chemical degradation pathways, including oxidation, hydrolysis, and deamidation, as well as physical degradation leading to aggregation or precipitation. pH is a paramount parameter influencing the peptide's stability and efficacy.
Safety
Safety Profile
Due to its potent mitogen and growth factor-mimicking properties, RH-POLYPEPTIDE-31 presents significant safety considerations. Research indicates a correlation between the overexpression of Insulin-like Growth Factor-2 (IGF-2)—which this peptide mimics—and the formation of hypertrophic scars in damaged skin, as well as a potential link to tumor progression. Consequently, its use requires strict adherence to product instructions or professional medical consultation. The ingredient's safety status has not been reviewed by the Cosmetic Ingredient Review (CIR).
Your Skin
Skin Compatibility
Our Assessment
Verdict
This ingredient is not recommended due to significant unaddressed safety concerns related to its growth factor-mimicking activity, including potential links to hypertrophic scarring and tumor progression, coupled with a 'not reviewed' CIR status.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources